In spermatozoa, as in other eukaryotic cells, integral membrane proteins may be anchored by a hydrophobic protein domain, or by a glycosylphosphatidylinositol (GPI) lipid anchor. Contrary to the current understanding of sperm membrane biogenesis, recent evidence shows that some of the GPI-anchored proteins are not synthesized by the spermatozoa themselves, but by cells of the male genital tract. They are transported to the fluid secretions, possibly associated with membrane vesicles, and then incorporate into the sperm membrane. This novel mechanism, by which proteins can move from the membrane of one cell to that of another in vivo, may account for a significant proportion of the surface changes occurring during sperm maturation. The function of these GPI-anchored molecules is largely unknown. However, they are remarkably abundant, and the phenomenon of cell-to-cell transfer seems to be well conserved across mammalian species. All of the post-testicularly acquired GPI-anchored proteins identified thus far have also been found on cells of the immune system (CD52, CD55, CD59, CD73), and we speculate that they may have a role in protecting spermatozoa from immune attack in the male and female reproductive tracts.
Introduction
Glycosylphosphatidylinositols (GPIs) are phospholipids found covalently linked to many membrane proteins. They provide the means by which these proteins are attached to the outer leaflet of the lipid bilayer. GPI anchors (Figure 1 ) are ubiquitous throughout the eukaryotes from the most primitive to the most complex. Their structure and biosynthesis have been well established during the last years, but the functions of GPIanchored proteins are diverse and less well understood (Ferguson and Williams, 1988; Low and Saltiel, 1988; Englund, 1993; McConville and Ferguson, 1993) . They include protozoal coats and adhesion proteins such as the variant surface glycoproteins of trypanosomes (VSGs), hydrolytic ectoenzymes such as alkaline phosphatase, mammalian neuronal adhesion proteins (N-CAM and related products), as well as cell surface antigens involved in signalling events during lymphocyte activation (e.g. Thy-1; Robinson, 1991) . Despite this broad spectrum of functions, the anchor structure ( Figure 1) shows a remarkable degree of conservation, suggestive of specialized roles (McConville and Ferguson, 1993; Anderson, 1993) .
Numerous reviews have documented the unique properties of GPI anchors which are postulated to be important for the function of the attached proteins (Ferguson and Williams, 1988; Low and Saltiel, 1988; Lisanti and Rodriguez-Boulan, 1990; Robinson, 1991; Anderson, 1993; Englund, 1993; McConville and Ferguson, 1993; Rosse, 1993) , including the following: (i) insulation of ectoplasmic domains from cytoplasm and cytoskeleton; (ii) ability to cluster within microdomains on the cell surface, possibly in association with © European Society for Human Reproduction and Embryology particular lipids; (iii) potential for lateral mobility within the lipid layer (though this is sometimes more restricted than expected); (iv) potential for unique sorting pathway and vectorial expression in polarized cells; (v) participation in signal transduction, possibly by interaction with tyrosine kinases (though the putative biochemical linkage and physiological triggers remain unknown), or by cleavage by specific phospholipases yielding both soluble ectodomains and biologically active phospholipids. Despite all these plausible roles for GPI anchors, few if any have been definitely shown to be specific. Rather, some of these molecules appear to function just as well when their GPI anchor is exchanged for a transmembrane protein anchor (Rother et al, 1994) .
However, to the above listed we can now add a novel function, i.e. the possibility of transfer of integral membrane proteins in vivo from one cell membrane to another, and this capacity of cell-to-cell transition may in fact be unique to the lipid anchored membrane proteins. Recently, Kooyman et al. (1995) have demonstrated that the GPI-anchored complement restriction factors CD55 and CD59 can be transferred from erythrocytes to the vascular epithelium in vivo.
Here we review data from an entirely different system, namely the male genital tract, suggesting that the cell-to-cell transfer phenomenon of GPI-anchored proteins has a more general biological significance. Transfer from the male genital tract epithelium to spermatozoa of complement restriction factors has already been suggested earlier (Rooney et al, 1993a; Rooney and Atkinson, 1994 Figure 1 . Generalized structure of a glycosylphosphatidylinositol (GPI)-anchored membrane protein (black bold) showing some of the substituents which may be found on the core structure. The shaded area includes the extracellular part of the molecule. EtN = ethanolamine; P = phosphate; Man = mannose; GalNAc = N-acetyl galactosamine; GlcN = glucosamine. 29-3J I) Mendoza et al., 1993 ; 2) Lopo and Vacquier, 1980;  3) Lin et al., 1994; 4) Lin el al., 1994; 5) Hale el al., 1990 : 6) Xia ei al., 1991 7) Xia et al.. 1993; 8) Treumann el al., 1995; 9) Rowan et al., 1994; 10) Kirchhoff el al., 1993; 11) Krull et al., 1993; 12) Hale e/a/., 1993; 13) Hale « a/., 1983; 14) Perry el al., 1992; 15) Kubota et al. 1990; 16) Kirchhoff, 1994; 17) Moore el al., 1989; 18) Eccleston et al., 1994 : 19) Ellerbrock et al., 1994 20) Rooney et al. 1992. 21) D'Cruz and Haas, 1993; 22) Cervoni et al. 1993; 23) Bozas el al.. 1993; 24) Simpson et al., 1994; 25) Rooney and Atkinson. 1993; 26) Hara et al., 1993; 27) Rooney et al., 1993a; 28) Fenichel et al., 1994; 29) Fabiani and Ronquist, 1993; 30) Riva, 1992: 31) Schiemann et al., 1994; 32) Zimmermann, 1992. proteins can be transferred to spermatozoa in the male genital tract, and also some indication that this transfer serves a physiological function during sperm maturation, sperm storage, and fertilization.
GPI-anchored molecules of the sperm plasma membrane
A number of GPI-anchored antigens are found on spermatozoa of various species, including human (Table I) . They are expressed at relatively high levels, and some of them show specific spatial patterns and redistribution on the sperm membrane during maturation, capacitation, and the acrosome reaction (Myles, 1993) . According to conventional dogma, any transmembrane molecule of spermatozoa should have been inserted during sperma-178 togenesis in the testis. The same seemed true for GPI-anchored proteins (Myles, 1993) . Addition of the GPI-anchor takes place within the lumen of the rough endoplasmic reticulum of the germ cells, most probably by transamidation cleaving of the C-terminal hydrophobic anchorage signal sequence (Englund, 1993) . GPI-protein/sphingolipid microdomains form in the Golgi apparatus and are packaged into apical transport vesicles for transport to the cell surface by the same route as conventional membrane proteins (Lisanti and Rodriguez-Boulan, 1990; Brown and Rose, 1992) . The PH-20 (sperm surface hyaluronidase) protein of mammalian spermatozoa (Phelps et al, 1988; Lin et al, 1993; Lin et al, 1994) and probably also the 63 kDa surface protein of sea urchin spermatozoa (Lopo and Vacquier, 1980; Mendoza et al, 1993) are examples of such sperm-specific GPI-anchored proteins which are synthesized during spermatogenesis by the developing germ cells themselves ( Table I ). The limited biosynthetic capacity of mature spermatozoa makes their post-testicular de-novo synthesis unlikely.
On the other hand, the sperm-bound decay accelerating factor (DAF, CD55), and CD59 (MACIP/protectin) may have another cellular source. Rooney et al (1992) and Rooney and Atkinson (1994) were among the first to describe their location on the sperm surface, suggesting an extra-or post-testicular source for these complement restriction factors. Meanwhile there are numerous publications describing their presence in the fluid secretions of the male reproductive tract and on spermatozoa (Rooney et al, 1992; D'Cruz and Haas, 1993; Cervoni et al, 1993; Bozas et al, 1993; Rooney and Atkinson, 1993; Hara et al, 1993; Rooney et al, 1993a; Fenichel et al, 1994; Simpson and Holmes, 1994) . Unlike their soluble forms found in urine, their lipid anchor in the seminal fluid forms appears to be intact, and the extracted antigens are able to reincorporate into cell membranes in vitro.
Sperm ecto-5' nucleotidase (which is probably identical to CD73, Table I ) seems to be an additional example of molecules which may be transferred to spermatozoa post-testicularly (Aumuller and Riva, 1992; Fabiani and Ronquist, 1993; Schiemann et al, 1994) . Synthesized and shed into the lumen by epithelial cells of the male genital tract, they seem to be transported to the sperm surface as constituents of vesicular organelles, the so-called 'prostasomes' (see below; Rooney et al, 1992 Rooney et al, , 1993a D'Cruz and Haas, 1993; Fabiani and Ronquist, 1993; Cervoni et al, 1993; Bozas et al, 1993; Atkinson, 1993, 1994; Hara et al, 1993; Simpson and Holmes, 1994; Fenichel et al, 1994) .
There is, however, also evidence for some endogenous synthesis in the testis (Cervoni et al, 1993; Simpson and Holmes, 1994; Schiemann et al, 1994) . Although the cell type of origin of sperm-bound CD55 (which is smaller than the lymphocyte surface molecule, probably as a result of differences in glycosylation, Cervoni et al, 1993; Simpson and Holmes, 1994) and CD59 as well as the relationship between sperm ecto-5' nucleotidase and CD73 (Aumuller and Riva, 1992; Zimmerman, 1992; Fabiani and Ronquist, 1993; Schiemann et al, 1994) remains to be established, intermembrane transfer as described for the vascular system (Kooyman et al, 1995) may be also used in the genital tract to replenish the sperm membrane post-testicularly of these molecules.
A GPI-anchored sperm membrane antigen of post-testicular origin
Remodelling of the sperm membrane by secretions of the genital tract epithelium, including the addition of new surface proteins, is an important aspect of post-testicular sperm maturation and storage (Brooks 1987; Orgebin-Crist, 1987; Jones, 1989; Cooper, 1992) . Typically, secretory proteins of the genital tract epithelium seem to be only loosely attached to the sperm surface (Brooks, 1987; Orgebin-Crist, 1987; Cooper, 1992; Myles, 1993) . The post-testicular origin of integral, GPIanchored sperm membrane proteins is striking and was not expected considering their established biosynthetic pathway (Englund, 1993) Figure 2 . Primary structure of the human CD52 antigen. The complete primary structure of the lymphocyte antigen has been defined by a combination of protein and cDNA sequencing (Xia et al., 1991) , amino acid and carbohydrate analysis (Xia et al., 1993) , carbohydrate structure determination and mass spectroscopy (Treumann et al., 1995) . This diagram illustrates the major components and shows the sites of enzymic cleavage which have been used during structure determination. EtN = ethanolamine; PO4 = phosphate; Man = mannose; GICNH2 = glucosamine. (Brown and Rose, 1992) , and their process of sorting to the apical membrane of epithelial cell types (Lisanti and Rodriguez-Boulan, 1990; Hannan et al, 1993 ). However, a major sperm membrane antigen has been identified which is synthesized only post-testicularly by the genital tract epithelium and transferred to the sperm surface with the GPI anchor intact: CD52 (CAMPATH-1/HE5 in human, 'B7' in mouse, SMemG in rat). The human CD52 (CAMPATH-1) antigen (Table I) is an unusually small GPI-anchored molecule which is abundantly expressed on lymphocytes (Hale et al, 1990; Xia et al, 1991 Xia et al, , 1993 . It contains only 12 amino acids and a single, complex N-linked oligosaccharide (Figure 2 ; Xia et al, 1991 Xia et al, , 1993 Treumann et al, 1995) . Monoclonal antibodies to it are remarkably effective for complement-mediated lysis and have proved to be very potent for lymphocyte depletion both in vitro and in vivo (Bindon et al, 1988; Isaacs et al, 1992) . Like other GPI-anchored antigens, CD52 is a target for antibody triggering of signalling and cell proliferation (Rowan et al, 1994 ) but its precise function has not yet been defined. A cDNA screening procedure designed to isolate major human epididymal gene products involved in sperm maturation yielded a major cDNA, named HE5, which turned out to be identical to the CAMPATH-1 cDNA . Transcripts are abundant in the epithelial cells of the distal epididymis and deferent duct and in blood lymphocytes, but never found in either spermatogenetic cells or spermatozoa, nor in the more proximal parts of the epididymis (Kirchhoff etal., 1993; Krull et al, 1993) .
Meanwhile, CAMPATH-l antibodies were found to react with parts of the male reproductive tract, particularly with the cauda epididymal epithelium and cauda fluid, and with epididymal but not testicular spermatozoa. The cross-reactivity persists in the ejaculate and on ejaculated spermatozoa (Hale et al, 1993) . Large amounts of CD52 antigen were found in seminal fluid in a very high molecular weight fraction, probably identical to the membrane vesicles known as 'prostasomes' (see below and Rooney et al, 1993) . Incubation of seminal plasma with erythrocytes resulted in an incorporation of some of the CD52 antigen into their membrane in vitro, just as previously described for the antigen purified from lymphocytes (Hale et al., 1993) . The results are consistent with the idea that the CD52 antigen is only produced post-testicularly by the genital tract epithelial cells, shed into the lumen by an unknown mechanism, and incorporated via its GPI-anchor into the sperm membrane (Figure 3 ).
Homologous GPI-anchored proteins have been described in the monkey (Hale et al, 1983; Perry et ai, 1992) , the mouse ('B7\ not to be confused with the mouse homologue of the human B7 antigen) (Kubota et ai, 1990) , the rat (Moore et ai, 1989; Eccleston et al, 1994; Kirchhoff, 1994) and the dog (Ellerbrock et ai, 1994) . In each case the pattern of expression 180 in the male reproductive tract is very similar: transcripts are found only post-testicularly, mainly in the distal epididymis, deferent duct and seminal vesicle. The antigen is found in the genital tract epithelium, in the seminal fluid and on spermatozoa. Where studied (monkey, mouse), the antigen is also found on lymphocytes. The predicted mature peptide sequences of the mouse (Kubota et al, 1990) , rat (Kirchhoff, 1994) and dog (Ellerbrock et al, 1994) antigens differ greatly from the human sequence, but they all share a single consensus site for N-linked glycosylation (Figure 4) . Genetic evidence for their homology comes from sequence comparisons of the N-terminal and C-terminal signal peptides (Kirchhoff, 1994) and from the non-translated parts of the genes, including a conserved intron location (Kirchhoff, 1996) .
Rat CD52 is a molecule that has been studied for many years since it was originally identified as the principal molecule of rat spermatozoa labelled by galactose oxidase/NaB[ 3 H] 4 (Olson and Hamilton, 1978; Jones et ai, 1981; Brown et ai, 1983; Zeheb and Orr, 1984; Hamilton et ai, 1986) . It has previously been known as 'major maturation-associated antigen' (Table I) or sperm membrane glycoprotein SMemG (Eccleston et ai, 1994) . The former name 'major maturationassociated antigen' describes the fact that its occurrence on the sperm surface in the epididymis coincides with the spermatozoa acquiring their major physiological properties of maturation. The molecule was generally thought to be a pre-existing integral sperm membrane molecule which is glycosylated, or in some way 'unmasked' during epididymal transit (Moore et al, 1989; Myles, 1993; Eccleston et ai, 1994) . However, one early report suggested that it was a major component of epididymal secretions which could be adsorbed onto or even inserted into the sperm membrane (Jones et al. 1981). The epididymal origin of the rat molecule was recently shown by cDNA cloning (Kirchhoff, 1994) . The mature peptide sequence predicted from the cDNA includes the partial peptide sequence published for SMemG (Eccleston et al, 1994) . Although there would appear to be evidence for a rearrangement of tryptic peptides, the sequencing data are otherwise consistent. There are ambiguities in the amino acid ratios (Eccleston et al, 1994) which seem to account for the differences. Since the mature CD52 peptide sequences which are found on the cell surface are so diverse (see Figure 4) , they may be just a scaffold for carbohydrate presentation. The peptide backbones of other highly glycosylated cell surface antigens, like CD24, CD35, and CD43, showing unfolded, extended structures due to glycosylation, are also only poorly conserved between species (for review see Barclay et al, 1993) . So far we know the structure of only the carbohydrate of the human lymphocyte CD52 (Treumann et al, 1995) . It consists of sialylated polylactosamine units attached to a tetra-antennary fucosylated mannose core. Several monoclonal antibodies to this type of carbohydrate have been found to bind to spermatozoa and inhibit fertilization, including one which was derived from an infertile woman with sperm-neutralizing antibodies (Tsuji et al, 1988; Kameda et al, 1992) .
Possible mechanism(s) of post-testicular acquisition by spermatozoa of GPI-anchored membrane proteins
Little is known about the mechanism(s) by which the observed cell-to-cell transfer is accomplished in vivo and whether different molecules in different systems are transferred by different mechanisms. According to a previous report host DAF can passively incorporate into trypanosomes in vivo (Pearce et al., 1990) . If the cell-to-cell transfer of GPI-anchored proteins is a passive process, a gradient may actually occur favouring transition (Kooyman et al, 1995) . Direct transfer may not be possible and the lipid anchor may require a carrier. Isolated CD59 will transfer to red blood cells in vitro employing high-density lipoprotein (HDL) as a carrier (Vakeva et al, 1994) . Similar mechanisms, based on gradients and/or carriers may be involved in the in-vivo transfer of CD52, CD55, CD59 (and CD73) from the genital tract epithelium to spermatozoa.
Seminal plasma contains a large quantity of multi-lamellar, cholesterol-rich membrane vesicles which may function as a carrier in vivo. The vesicles are called 'prostasomes' because they are thought to be all produced by the prostate gland (Ronquist and Brody, 1985) . Although the prostasomes of human seminal plasma seem to be distinct by certain markers (Kelly, 1995) similar vesicles seem to be produced by the epididymis (Fornes et al, 1995) , the vas deferens (Manin et al, 1995) , and the seminal vesicle (Aumuller and Seitz, 1990) . The 'soluble' GPI-anchored antigens of the seminal fluid are found to be at least in part associated with these vesicles (Rooney et al, 1993a,b; Atkinson, 1993, 1994; Fabiani and Ronquist, 1993; G.AumUller, personal communication; G.Hale, unpublished results) , and they may have been released from the apical cell membrane of the genital tract epithelium by shedding of these vesicles (Rooney et al, 1993a; Rooney and Atkinson, 1994) . Fusion of 'prostasomes' with the sperm membrane would provide a mechanism for post-testicular and supplementary acquisition of the GPIanchored antigens which is specific to spermatozoa and the genital tract.
Possible physiological role(s) of GPI anchormediated cell-to-cell transfer of membrane proteins
Among the best studied organisms in which the GPI membrane anchor is found-in much higher frequency than in higher eukaryotes-are the parasitic flagellate protozoa (McConville and Ferguson, 1993) . For these cells, protection against immune attack and complement-mediated lysis by their host are essential for their survival. A dense glycocalix built by GPI-anchored molecules masking proteinous membrane antigens is part of their 'defense strategy'. Additionally, data obtained by Pearce et al. (1990) suggest that schistosomes may evade a complement attack by their host by inserting functional host DAF into their surfaces, most probably by making use of the molecule's lipophilic anchor moiety for insertion into the outer lipid bilayer of the parasite.
By analogy, for the survival of spermatozoa in the male (and female) reproductive tracts the masking of proteinaceous antigens by post-testicular acquisition of a glycocalix and insertion of complement restriction factors may be equally important. The concentration of putative autoantigens on epididymal spermatozoa equals (or even may exceed) that of the testis. This makes the epididymis a probable site of initiation of an antisperm autoimmune response (Fichorova et al, 1995) . The build-up of a glycocalix by the highly glycosylated and sialylated CD52 molecules (Figures 2 and 3 ) might provide an effective protection for the cells. It occurs in a region of the male genital tract where the testicular mechanisms of preventing anti-sperm autoimmune responses may be no longer effective. In this context it may not be a coincidence that at least in primates and mouse the 'major maturation-associated' sperm membrane antigen, CD52, is also an abundant surface molecule of lymphocytes. Spermatozoa which are 'foreign' to the male (and female) immune system could 'hide' behind a sialylated, lymphocyte-like glycocalix during epididymal storage and passage through the female tract, thereby evading the immune system. In addition, although spermatozoa do not seem to be immune to complement attack (D'Cruz and Haas, 1993) supplementary transfer of CD55 and CD59 might ensure an even distribution of these proteins to confer at least some protection against complement attack.
Semen is known to be immunosuppressive, and whilst much of this activity is due to prostaglandins, it has also been suggested that the 'prostasomes' are a powerful immunosuppressive component (Kelly, 1995) . They inhibit both mitogen induced proliferation of lymphocytes (Kelly et al, 1991) and phagocytosis by macrophages or granulocytes as well as superoxide production by granulocytes (Skibinski et al, 1992) . They are also reported to modulate measles virus infection (Kitamura et al, 1995) . Just as is seems possible for 'prostasomes' to deliver some or all of the membrane 182 components to spermatozoa, they can also attach to other cells such as leukocytes (Skibinski et al, 1992) . This may result in suppression or diversion of an immune response against spermatozoa, and thus finally enhance the chance of conception.
If a GPI-anchored molecule is primarily involved in protection from immune attack and/or cell recognition, then its function might be exerted during sperm storage and early in the process of fertilization, i.e. during passage through the female genital tract. It may no longer be required during gamete recognition, zona binding and fusion of the gametes, and may then be released by a GPI-specific phospholipase activity analogous to those found in plasma (Low, 1992) , thereby either leaving other sperm surface constituents unperturbed or triggering signal transduction processes connected to capacitation or the acrosome reaction. Mouse spermatozoa seem to loose distinct GPI-anchored components from their surface during the acrosome reaction (Thaler and Cardullo, 1995) . However, there remains also the possibility that some of the glycoproteins displayed on these anchors could have a more direct role in fertilization.
Conclusions
In the vascular system, GPI-anchored proteins can move from the membrane of one cell to that of another by means of their lipid anchor. In the male reproductive system, direct evidence demonstarting a movement of 'tagged' GPI-anchored proteins is still lacking. Nevertheless, study of their expression patterns, although providing mainly indirect evidence, has uncovered a new aspect of this class of molecules, namely the post-testicular intermembrane transfer from cells of the genital tract epithelium to spermatozoa during sperm maturation. This phenomenon seems to be highly conserved among mammalian species. Thus, in-vivo cell-to-cell transfer is not restricted to the transgenic mouse model described by Kooyman et al. (1995) and not to the complement restriction factors CD55 and CD59, but may rather represent a general characteristic of GPIanchored proteins. Moreover, the elucidation of the posttesticular transfer of membrane proteins from the genital tract epithelium to spermatozoa suggests that the phenomenon serves a physiological function: the identification of certain major GPI-anchored sperm membrane proteins as also being abundant components of the immune system makes us think that they have a role in protection of spermatozoa from immune attack during maturation, storage and fertilization. Whether this may be the only physiological significance of their posttesticular transfer to the sperm surface, or whether some of them have a more direct role in the acrosome reaction, gamete recognition, binding and fusion is subject to future research.
